Transcranial Non-Invasive Brain Stimulation in Parkinson's Disease Patients with Dyskinesias. Where is the Optimal Target?
Cerebellum
.
2017 Feb;16(1):276-278.
doi: 10.1007/s12311-016-0768-y.
Authors
Antonio Cerasa
1
,
Ignacio Obeso
2
3
,
Michele Dileone
2
4
,
Aldo Quattrone
5
6
Affiliations
1
IBFM, National Research Council, Catanzaro, 88100, Italy. a.cerasa@unicz.it.
2
Centro Integral en Neurociencias A.C. (CINAC), HM Hospitales- Puerta del Sur, Madrid, Spain.
3
Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
4
Department of Neurosciences, San Bortolo Hospital, Vicenza, Italy.
5
IBFM, National Research Council, Catanzaro, 88100, Italy.
6
Institute of Neurology, University Magna Graecia, Catanzaro, Italy.
PMID:
26928908
DOI:
10.1007/s12311-016-0768-y
No abstract available
Publication types
Letter
Comment
MeSH terms
Cerebellum
Dyskinesia, Drug-Induced*
Humans
Levodopa
Parkinson Disease*
Substances
Levodopa